Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
2018 ◽
Vol 67
(12)
◽
pp. 1919-1929
◽
2015 ◽
2011 ◽
2004 ◽
Vol 64
(17)
◽
pp. 6337-6343
◽
Keyword(s):